Aurore Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 50.00 Cr
as on 11-07-2024
- Paid Up Capital ₹ 42.11 Cr
as on 11-07-2024
- Company Age 7 Year, 7 Months
- Last Filing with ROC 31 Mar 2022
- Open Charges ₹ 165.50 Cr
as on 11-07-2024
- Revenue 133.38%
(FY 2022)
- Profit -71.66%
(FY 2022)
- Ebitda -131.92%
(FY 2022)
- Net Worth -89.37%
(FY 2022)
- Total Assets 15.10%
(FY 2022)
About Aurore Pharmaceuticals
The Corporate was formerly known as Sphery Lifesciences Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2022. It's a company limited by shares with an authorized capital of Rs 50.00 Cr and a paid-up capital of Rs 42.11 Cr.
The company currently has active open charges totaling ₹165.50 Cr.
The Key Managerial Personnel (KMP) at Aurore Pharmaceuticals Private Limited India is Vamsilatha Thulasi as COMPANY SECRETARY. Rajender Rao and Sareddy Ravisankara serve as directors at the Company.
- CIN/LLPIN
U24239TG2017PTC117032
- Company No.
117032
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
15 May 2017
- Date of AGM
31 Dec 2022
- Date of Balance Sheet
31 Mar 2022
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
Hyderabad, Telangana, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Aurore Pharmaceuticals?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Vamsilatha Thulasi  | Company Secretary | Current |
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Rajender Rao | Director | 11-Jun-2018 | Current |
| Sareddy Ravisankara | Nominee Director | 06-Dec-2022 | Current |
Financial Performance and Corporate Structure Insights of Aurore Pharmaceuticals.
Aurore Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 133.38% increase. The company also saw a substantial fall in profitability, with a 71.66% decrease in profit. The company's net worth observed a substantial decline by a decrease of 89.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Aurore Pharmaceuticals?
In 2022, Aurore Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Aurore Life Sciences Private LimitedActive 8 years 2 monthsVamsilatha Thulasi and Rajender Rao are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 15 Jun 2018 | ₹62.50 Cr | Open |
Yes Bank Limited Creation Date: 29 May 2018 | ₹103.00 Cr | Open |
How Many Employees Work at Aurore Pharmaceuticals?
Aurore Pharmaceuticals has a workforce of 451 employees as of Apr 08, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Aurore Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aurore Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
